Literature DB >> 22605714

Pleomorphic xanthoastrocytoma with malignant transformation and multiple recurrences in an Iranian girl.

Fariba Binesh1, Ali Akhavan, Hossein Navabii.   

Abstract

Pleomorphic xanthoastrocytoma (PXA) is a rare astrocytic tumour of the brain. Some PXAs are accompanied by anaplastic features and are difficult to manage because of frequent recurrences that lead to early death. Well-documented cases of malignant transformation in PXA and of anaplastic PXA are rare in the literature. The authors report a case of PXA with malignant transformation in the right temporo occipital lobe in a 13-year-old Iranian girl.

Entities:  

Mesh：

Year:  2012        PMID： 22605714      PMCID： PMC3316851          DOI： 10.1136/bcr.12.2011.5372

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  29 in total

1.  Malignant transformation in pleomorphic xanthoastrocytoma--a report of two cases.

Authors:  A Chakrabarty; P Mitchell; L R Bridges; A J Franks
Journal:  Br J Neurosurg       Date:  1999-10       Impact factor: 1.596

2.  Pleomorphic xanthoastrocytoma: what do we really know about it?

Authors:  C Giannini; B W Scheithauer; P C Burger; D J Brat; P C Wollan; B Lach; B P O'Neill
Journal:  Cancer       Date:  1999-05-01       Impact factor: 6.860

3.  Neurofibromatosis type 1-associated unusual pleomorphic astrocytoma displaying continual malignant progression.

Authors:  H Yokoo; M Kamiya; A Sasaki; J Hirato; Y Nakazato; H Kurachi
Journal:  Pathol Int       Date:  2001-07       Impact factor: 2.534

Review 4.  Composite pleomorphic xanthoastrocytoma and ganglioglioma: report of four cases and review of the literature.

Authors:  A Perry; C Giannini; B W Scheithauer; A M Rojiani; A T Yachnis; I S Seo; P C Johnson; J Kho; S Shapiro
Journal:  Am J Surg Pathol       Date:  1997-07       Impact factor: 6.394

5.  Pediatric cerebellar pleomorphic xanthoastrocytoma with anaplastic features: a case of long-term survival after multimodality therapy.

Authors:  Howard T Chang; Julius Gene S Latorre; Seung Hahn; Ronald Dubowy; Robert L Schelper
Journal:  Childs Nerv Syst       Date:  2006-03-29       Impact factor: 1.475

6.  Glioblastoma multiforme masquerading as a pleomorphic xanthoastrocytoma.

Authors:  S J Gaskill; A E Marlin; V Saldivar
Journal:  Childs Nerv Syst       Date:  1988-08       Impact factor: 1.475

7.  Anaplastic pleomorphic xanthoastrocytoma.

Authors:  C Bayindir; N Balak; A Karasu; D Kasaroğlu
Journal:  Childs Nerv Syst       Date:  1997-01       Impact factor: 1.475

Review 8.  Pleomorphic xanthoastrocytoma. Ultrastructural and immunohistochemical study of a case with a rapidly fatal outcome following surgery.

Authors:  C M Weldon-Linne; T A Victor; D R Groothuis; N A Vick
Journal:  Cancer       Date:  1983-12-01       Impact factor: 6.860

Review 9.  Primary anaplastic pleomorphic xanthoastrocytoma with widespread neuroaxis dissemination at diagnosis--a pediatric case report and review of the literature.

Authors:  Toshiyuki Okazaki; Teruyoshi Kageji; Kazuhito Matsuzaki; Hidehisa Horiguchi; Takanori Hirose; Hiroyoshi Watanabe; Toshihiro Ohnishi; Shinji Nagahiro
Journal:  J Neurooncol       Date:  2009-03-27       Impact factor: 4.130

10.  Long-term control of disseminated pleomorphic xanthoastrocytoma with anaplastic features by means of stereotactic irradiation.

Authors:  Tomoyuki Koga; Akio Morita; Keisuke Maruyama; Minoru Tanaka; Yasushi Ino; Junji Shibahara; David N Louis; Guido Reifenberger; Jun Itami; Ryusuke Hara; Nobuhito Saito; Tomoki Todo
Journal:  Neuro Oncol       Date:  2009-01-22       Impact factor: 12.300
View more
  7 in total

1.  BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.

Authors:  Matthew Mistry; Nataliya Zhukova; Daniele Merico; Patricia Rakopoulos; Rahul Krishnatry; Mary Shago; James Stavropoulos; Noa Alon; Jason D Pole; Peter N Ray; Vilma Navickiene; Joshua Mangerel; Marc Remke; Pawel Buczkowicz; Vijay Ramaswamy; Ana Guerreiro Stucklin; Martin Li; Edwin J Young; Cindy Zhang; Pedro Castelo-Branco; Doua Bakry; Suzanne Laughlin; Adam Shlien; Jennifer Chan; Keith L Ligon; James T Rutka; Peter B Dirks; Michael D Taylor; Mark Greenberg; David Malkin; Annie Huang; Eric Bouffet; Cynthia E Hawkins; Uri Tabori
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

2.  Comprehensive analysis of Iranian reports of pediatric central nervous system tumors.

Authors:  Narjes Mehrvar; Azim Mehrvar; Mohammad Esmaeil Akbari; Ibrahim Qaddoumi
Journal:  Childs Nerv Syst       Date:  2017-05-29       Impact factor: 1.475

3.  A Rare Case of Metastases from a High-grade Astrocytoma to the Pleura, Bones, and Liver within Six Months of Diagnosis.

Authors:  Jennifer Dotson; Ala Nijim; Krista L Denning; Yousef Shweihat; Yehuda Lebowicz
Journal:  Cureus       Date:  2018-08-30

4.  A rare clinical presentation: a pleomorphic xanthoastrocytoma presenting with intracerebral haemorrhage and metastasizing vigorously-case report and review of the literature.

Authors:  Gülden Demirci Otluoğlu; M Memet Özek
Journal:  Childs Nerv Syst       Date:  2018-09-04       Impact factor: 1.475

5.  Demography, Pattern of Care, and Survival in Patients with Xanthoastrocytoma: A Systematic Review and Individual Patient Data Analysis of 325 Cases.

Authors:  Supriya Mallick; Prashanth Giridhar; Rony Benson; Wineeta Melgandi; Goura Kishor Rath
Journal:  J Neurosci Rural Pract       Date:  2019-10-07

6.  Malignant transformation of pleomorphic xanthoastrocytoma in pregnant patient: Clinical case and ethical dilemma.

Authors:  Jurica Marakovic; Darko Chudy; Danko Muller; Damir Tomac; Petar Marcinkovic; Darko Oreskovic; Andjelo Kastelancic; Marina Raguz
Journal:  Surg Neurol Int       Date:  2021-09-20

7.  Malignant transformation of pleomorphic xanthoastrocytoma and differential diagnosis: case report.

Authors:  Noriyuki Watanabe; Eiichi Ishikawa; Hidehiro Kohzuki; Noriaki Sakamoto; Alexander Zaboronok; Masahide Matsuda; Makoto Shibuya; Akira Matsumura
Journal:  BMC Neurol       Date:  2020-01-15       Impact factor: 2.474
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.